Comparing Cardiac Output Measurements Using a Wearable, Wireless, Non-invasive PPG-Based Device to a Swan Ganz Catheter
1 other identifier
observational
100
1 country
1
Brief Summary
Invasive pulmonary capillary wedge pressure measurements using a Swan-Ganz catheter (SGC) is considered the gold standard for cardiac output (CO) monitoring. In this prospective study, we will compare CO measurements between a PPG-based wearable monitor and a SGC in ambulatory CHF patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 4, 2021
CompletedFirst Posted
Study publicly available on registry
July 8, 2021
CompletedStudy Start
First participant enrolled
October 10, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 25, 2022
CompletedJuly 20, 2022
December 1, 2021
8 months
July 4, 2021
July 19, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Comparison of cardiac output obtained by a non-unvasive device to the invasive method
In each participant, a Swan-Ganz catheter will be inserted as part of their routine assessment, and cardiac output measurements will be compared with a non-invasive wearable and wireless PPG-based device.
2-4 hours per patient
Interventions
non-invasive measurements of cardiac output
Eligibility Criteria
Adult patients from both sexes with CHF arriving for an ambulatory assessment using a Swan-Ganz catheter in the Medical Center's Cath-lab.
You may qualify if:
- Patients with CHF
You may not qualify if:
- Pregnant women
- Pediatric patients
- Inability to sign an informed consent form
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Biobeat Technologies Ltd.lead
- Hadassah Medical Organizationcollaborator
Study Sites (1)
The Hadassah Ein Kerem Medical Center
Jerusalem, 91120, Israel
Related Publications (1)
Nachman D, Eisenkraft A, Rahamim E, Ibrahimli M, Asenov A, Goldstein N, Kolben Y, Huly S, Ben Ishay A, Fons M, Tabi M, Merin R, Amir O, Asleh R. Assessing Cardiac Flow Measurements Using a Noninvasive Photoplethysmography-Based Device Compared to Invasive Pulmonary Artery Catheter. JACC Adv. 2025 Sep;4(9):102093. doi: 10.1016/j.jacadv.2025.102093. Epub 2025 Aug 22.
PMID: 40845743DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dean Nachman, MD
The Institute for Research in Military Medicine
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 4, 2021
First Posted
July 8, 2021
Study Start
October 10, 2021
Primary Completion
June 15, 2022
Study Completion
June 25, 2022
Last Updated
July 20, 2022
Record last verified: 2021-12